Branded

AbbVie receives FDA blessing for new Rinvoq indication

Rinvoq provides treatment for adults with active psoriatic arthritis who have had an inadequate response or intolerance to one or more tumor necrosis factor blockers.
Novartis receives FDA nod for new indication of Cosentyx

Cosentyx is now approved for the treatment of children and adolescents with enthesitis-related arthritis and psoriatic arthritis, the company said.
Novartis receives FDA OK for Leqvio

Novartis has obtained global rights to develop, manufacture and commercialize Leqvio under a license and collaboration agreement with Alnylam Pharmaceuticals.
FDA gives EU authorization for Molnupiravir

Molnupiravir received emergency use authorization for mild-to-moderate COVID-19 in adults.
Allergan debuts Vuity

Allergan’s Vuity is the first eye drop to treat presbyopia (age-related blurry near vision).
Azurity Pharmaceuticals gets FDA OK for Eprontia

Eprontia provides a ready-to-use liquid medication for patients who have trouble swallowing pills.
Tris Pharma acquires FDA OK for Dyanavel

Dyanavel XR offers treatment for patients age 6 years old and older with ADHD.
FDA gives ANI green light for Cortrophin Gel

Cortrophin Gel is purified corticotropin, an important treatment option for patients struggling with certain chronic autoimmune disorders, the company said.

Pfizer gets FDA OK for new Xeljanz indication